Business & Finance
Genelabs Technologies completes sale of diagnostics business
Published in Hepatitis Weekly, May 17th, 2004
In the transaction, Genelabs sold all of the outstanding common and preferred stock of Genelabs Asia Pte., Ltd., (GLA) to MP Biomedicals. Prior to the sale, GLA, the parent company of Genelabs Diagnostics Pte., Ltd., (GLD) was a wholly owned subsidiary of Genelabs Technologies. GLD is a Singapore-based company that develops, manufactures, and markets diagnostics products primarily in Europe and Asia.
"The divestment of our diagnostics operations reinforces our intention to maintain a sharp focus on our core drug-discovery and -development...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-05-17)
More Articles from Hepatitis Weekly
- Cancer Risk Factor
Unique gene sets distinguish cirrhosis patients with a risk for liver cancer - Chronic Liver Disease
Pioglitazone shows promise for treating non-alcoholic steatohepatitis - Immunology
Hepatitis C patients have fibrosis progression when T cell response falters - Transgenics
New transgenic mice could serve as models for hepatitis B-related liver cancer - Transplant Medicine
Erythropoietin may benefit patients with post-liver-transplant anemia - Addiction Medicine
Beliefs about HCV status affect drug users' health-related quality of life - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
